Romano Brothers & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Romano Brothers & Co's LLY Position: Q2 2026 in Review
Romano Brothers & Co reduced its Eli Lilly (LLY) stake by 3.7% in Q2 2026, selling an estimated $220K and leaving 5,634 shares worth $6.76M. The position accounts for 0.68% of the portfolio, ranked #41.
Romano Brothers & Co first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Romano Brothers & Co held 5,634 shares of Eli Lilly worth $6.76M as of Q2 2026.
- Romano Brothers & Co sold 215 Eli Lilly shares in Q2 2026, an estimated $220K.
- Eli Lilly made up 0.68% of Romano Brothers & Co's portfolio in Q2 2026, its #41 holding.
- Romano Brothers & Co first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.